SARDA PROTEINS LTD. - 519242 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the extract of Un-audited Financial Results for the quarter and half year ended on 30th September, 2022 published by the Company in The Indian Express (English) and Business Remedies (Hindi) Newspaper on 20th October, 2022. SARDA PROTEINS LTD. - 519242 - Un-Audited Financial Results For The Quarter And Half Year Ended On 30Th September, 2022
Approved the Un-audited Financial Results of the company for the quarter and half year ended on 30th September, 2022 along with the Statement of Assets and Liabilities as on 30th September, 2022 and Statement of Cash Flow for the half year ended on 30th September, 2022 and took on record the Limited Review Report thereon. (Enclosed as Annexure-A) Further, the extract of the Un-audited Financial Results would also be published in the newspapers in compliance with Regulation 47 of Listing Regulations. SARDA PROTEINS LTD. - 519242 - Board Meeting Outcome for Outcome Of The Board Meeting For Approval Of Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2022
Approved the Un-audited Financial Results of the company for the quarter and half year ended on 30th September, 2022 along with the Statement of Assets and Liabilities as on 30th September, 2022 and Statement of Cash Flow for the half year ended on 30th September, 2022 and took on record the Limited Review Report thereon. (Enclosed as Annexure-A) Further, the extract of the Un-audited Financial Results would also be published in the newspapers in compliance with Regulation 47 of Listing Regulations. SARDA PROTEINS LTD. - 519242 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AMIT KUMAR MODIDesignation :- Company Secretary and Compliance Officer SARDA PROTEINS LTD. - 519242 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended On 30Th September, 2022
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2022 ,inter alia, to consider and approve i. To approve the Un-audited Financial Results of the company for the quarter and half year ended on 30th September, 2022 along with the Statement of Assets and Liabilities as on 30th September, 2022 and Statement of Cash Flow for the half year ended on 30th September, 2022; ii. To take on record the Limited Review Report on the Un-audited Financial Results for the quarter and half year ended on 30th September, 2022. SARDA PROTEINS LTD. - 519242 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We hereby enclose herewith the Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th September, 2022 received from M/s Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company. SARDA PROTEINS LTD. - 519242 - Closure of Trading Window
This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended) read with the Company''s Code of Conduct to regulate, monitor and report trading, the Trading Window for trading in the securities of the Company shall remain closed for Designated Persons of the Company and their relatives from 01st October, 2022 till 48 hours after the announcement of the Financial Results of the Company for the quarter and half-year ended on 30th September, 2022. The date of meeting of the Board of Directors to approve the Financial Results of the Company for the quarter and half-year ended on 30th September, 2022 will be informed in due course. SARDA PROTEINS LTD. - 519242 - Shareholder Meeting-Voting Results
Pursuant to regulation 44 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the details of voting results (through remote e-voting and e-voting during AGM) of the business transacted at the 31st Annual General Meeting of the Company held on Friday, September 23, 2022. SARDA PROTEINS LTD. - 519242 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, please find attached the Scrutinizer's Report on Remote E-Voting & E-Voting conducted at the 31st Annual General Meeting of the company held on Friday, September 23, 2022. SARDA PROTEINS LTD. - 519242 - Shareholder Meeting / Postal Ballot-Outcome of AGM
In pursuance of Regulation 30 and Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the proceedings of 31st AGM of the Members of the Company held on Friday, September 23, 2022 at 12:30 P.M. through Video Conferencing.